The DHL Group has completed the expansion of its Life Sciences & Healthcare Campus in Florstadt, Hesse. According to the company, the new logistics center Florstadt 4 is becoming one of the central European hubs for pharmaceutical products. The announcement states that the location will play a key role in DHL Health Logistics' global network in the future.
With the fourth warehouse, DHL expands the total usable area of the campus to around 100,000 square meters. The new facility covers 30,000 square meters and has been designed for temperature-sensitive pharmaceutical and medical products. Products can be stored in multiple temperature zones, including cooling areas between 2 and 8 degrees Celsius and deep-freeze areas down to -70 degrees. According to DHL, this enables the location to meet the highest demands in the storage and distribution of
sensitive biopharmaceutical products.
The new Florstadt 4 location offers around 140,000 pallet spaces and employs more than 600 professionals. They support international customers from the fields of biopharma, specialty pharma, medical technology, and clinical research. In addition to storage, the team also provides services such as sampling, support for clinical trials, or handling cell and gene therapies.
A key feature of the expansion is the integrated cleanroom. This allows GMP-compliant processes for pharmaceutical raw materials, including the handling of solid and liquid hazardous substances as well as APIs and active ingredient samples. DHL emphasizes that the facility meets international pharmaceutical standards and is designed for highly specialized requirements.
Hendrik Venter, CEO DHL Supply Chain for Europe, the Middle East, and Africa, classifies the location as an important part of the growth strategy.
“With the now
fourth expansion, we are creating future capacities in Florstadt: From here we supply customers not only in Germany but throughout Europe – and beyond,” says Venter.
The geographical location near Frankfurt and the transport connections played a central role in the choice of location.
Oscar de Bok, Global CEO DHL Supply Chain, sees Florstadt as a central element of the DHL Group's long-term investment strategy.
“Florstadt 4 is a prime example of how we are implementing our 2030 strategy in concrete terms: with total investments of two billion euros by 2030, we are strengthening our global DHL Health Logistics network,” explains de Bok.
The location is a backbone for end-to-end supply chain solutions in the field of modern therapies.
In terms of digitalization and transparency, DHL speaks of “new standards.” The warehouse management system is
directly linked to the customers' IT systems, which is particularly important for patient-specific products such as clinical trials or temperature-sensitive specialty medications. Through close integration, DHL aims to make the management of complex supply chains more efficient.
Rainer Haag, CEO DHL Supply Chain Germany & Alps, on economic aspects: “The Frankfurt-Rhine-Main region is one of the most significant economic centers in Europe. That we are continuously expanding our largest LSH campus in Germany right here shows how important Florstadt is as the heart of our DHL Health Logistics strategy.”
In addition to logistics infrastructure, sustainability plays a central role. The new warehouse building is designed to be climate-neutral and features solar thermal energy, air heat pumps, LED light control, and a photovoltaic system. The German Sustainable Building Council has awarded the project the DGNB Gold
